Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026)
Natera (NTRA) reported Non-Current Deferred Tax Liability of $701000.0 for Q1 2026, little changed quarter-over-quarter from $701000.0 in Q4 2025.
Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Natera has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $701000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $701000.0; the trailing twelve-month figure through Mar 2026 stood at $701000.0 (changed N/A YoY), and the FY2025 full-year result was $701000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $701000.0, roughly flat from $701000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $701000.0 in Q4 2025, with the low at $701000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 701,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |